Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy-Author's reply

被引:0
|
作者
Ogawa, Eiichi [1 ,2 ]
机构
[1] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka, Japan
[2] Kyushu Univ Hosp, Dept Gen Internal Med, 3-1-1 Maidashi,Higashi Ku, Fukuoka 8128582, Japan
关键词
D O I
10.1111/apt.17693
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
LINKED CONTENT This article is linked to Ogawa et al papers. To view these articles, visit and
引用
收藏
页码:845 / 846
页数:2
相关论文
共 50 条
  • [1] Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy
    Su, Jia-Yong
    Wu, Ying-Ling
    Wu, Xuan-Lin
    Liu, Zhen-Xiu
    Wang, Yi-Yang
    Li, Zhong-Hai
    Luo, Jia-Xin
    Wu, Kun-Jun
    Zhong, Jian-Hong
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (08) : 842 - 844
  • [2] Entecavir versus tenofovir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy
    Kao, Wei-Yu
    Tan, Elise Chia-Hui
    Lee, Hsin-Lun
    Huang, Yi-Hsiang
    Huo, Teh-Ia
    Chang, Chun-Chao
    Chiou, Jeng-Fong
    Hou, Ming-Chih
    Wu, Jaw-Ching
    Su, Chien-Wei
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (11) : 1299 - 1312
  • [3] Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy
    Chang, Kai-Chun
    Su, Tung-Hung
    Liao, Sih-Han
    Tseng, Tai-Chung
    Huang, Shang-Chin
    Hsu, Shih-Jer
    Hong, Chun-Ming
    Liu, Chen-Hua
    Yang, Hung-Chih
    Liu, Chun-Jen
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 (08) : 891 - 898
  • [4] Tenofovir is superior to entecavir on recurrence in hepatitis B virus-related hepatocellular carcinoma after curative resection
    Tsai, Ming-Chao
    Wang, Chih-Chi
    Lee, Wei-Chen
    Liu, Yueh-Wei
    Lin, Chih-Che
    Hu, Tsung-Hui
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 163 - 163
  • [5] Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection
    Xiao-Hui Wang
    Zi-Li Hu
    Yi-Zhen Fu
    Jing-Yu Hou
    Wen-Xuan Li
    Yao-Jun Zhang
    Li Xu
    Qun-Fang Zhou
    Min-Shan Chen
    Zhong-Guo Zhou
    Journal of Gastroenterology, 2022, 57 : 185 - 198
  • [6] Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection
    Wang, Xiao-Hui
    Hu, Zi-Li
    Fu, Yi-Zhen
    Hou, Jing-Yu
    Li, Wen-Xuan
    Zhang, Yao-Jun
    Xu, Li
    Zhou, Qun-Fang
    Chen, Min-Shan
    Zhou, Zhong-Guo
    JOURNAL OF GASTROENTEROLOGY, 2022, 57 (03) : 185 - 198
  • [7] Real-world based cost effectiveness analysis of entecavir versus tenofovir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy
    Ho, Chun-Ting
    Su, Chien-Wei
    Tan, Elise Chia-Hui
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    Wu, Jaw-Ching
    JOURNAL OF HEPATOLOGY, 2024, 80 : S663 - S664
  • [8] Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection
    Choi, Jonggi
    Jo, Chanyoung
    Lim, Young-Suk
    HEPATOLOGY, 2021, 73 (02) : 661 - 673
  • [9] Letter to the Editor: Re: Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection
    Kim, Beom Kyung
    Kim, Seung Up
    HEPATOLOGY, 2021, 73 (01) : 466 - 466
  • [10] The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma
    Lee, Ji Hyun
    Kim, Beom Kyung
    Park, Soo Young
    Tak, Won Young
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Sinn, Dong Hyun
    Kim, Seung Up
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 89 : 48 - 55